1.Imidacloprid inhibits IgE-mediated RBL-2H3 cell degranulation and passive cutaneous anaphylaxis
Linbo SHI ; Li ZOU ; Jinyan GAO ; Huaing XU ; Xiaoyun SHI ; Hongbing CHEN
Asia Pacific Allergy 2016;6(4):236-244
BACKGROUND: Imidacloprid has been commonly used as a pesticide for crop protection and acts as nicotinic acetylcholine receptor agonists. Little information about the relationship between imidacloprid and allergy is available. OBJECTIVE: This study aims to examine the effects of imidacoprid on IgE-mediated mast cell activation. METHODS: The rat basophilic leukemia cell line RBL-2H3 (RBL-2H3 cells) were treated with 10⁻³ – 10⁻¹² mol/L imidacloprid, followed by measuring the mediator production, influx of Ca²⁺ in IgE-activated RBL-2H3 cells, and the possible effects of imidacoprid on anti-dinitrophenyl IgE-induced passive cutaneous anaphylaxis (PCA). RESULTS: It was shown that imidacoprid suppressed the production of histamine, β-hexosaminidase, leukotriene C4, interleukin-6, tumor necrosis factor-α, and Ca²⁺ mobilization in IgE-activated RBL-2H3 cells and decreased vascular extravasation in IgE-induced PCA. CONCLUSION: It is the first time to show that imidacloprid suppressed the activation of RBL-2H3 cells.
Animals
;
Basophils
;
Cell Degranulation
;
Cell Line
;
Crop Protection
;
Histamine
;
Hypersensitivity
;
Interleukin-6
;
Leukemia
;
Leukotriene C4
;
Mast Cells
;
Necrosis
;
Passive Cutaneous Anaphylaxis
;
Rats
;
Receptors, Nicotinic